PROFUSA Debt to Equity Ratio 2022-2021 | PFSA

Current and historical debt to equity ratio values for PROFUSA (PFSA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. PROFUSA debt/equity for the three months ending September 30, 2021 was 0.00.
PROFUSA Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2021-09-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.010B $0.000B
Profusa Inc. is a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual's biochemistry. Profusa Inc., formerly known as NorthView Acquisition Corp., is based in BERKELEY, Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $47.813B 60.83
Hims & Hers Health (HIMS) United States $13.134B 136.46
Doximity (DOCS) United States $11.457B 53.04
Tempus AI (TEM) United States $10.733B 0.00
IRhythm Technologies (IRTC) United States $4.377B 0.00
Inspire Medical Systems (INSP) United States $3.856B 60.24
Hinge Health (HNGE) United States $3.535B 0.00
Privia Health (PRVA) United States $2.402B 164.17
10x Genomics (TXG) United States $1.803B 0.00
Schrodinger (SDGR) United States $1.643B 0.00
Phreesia (PHR) United States $1.614B 0.00
Azenta (AZTA) United States $1.562B 72.62
Enovis (ENOV) United States $1.561B 8.70
Clover Health Investments (CLOV) United States $1.527B 0.00
Omnicell (OMCL) United States $1.358B 23.97
Evolent Health (EVH) United States $1.133B 96.50
Claritev (CTEV) United States $0.664B 0.00
Fulgent Genetics (FLGT) United States $0.549B 0.00
Standard BioTools (LAB) United States $0.539B 0.00
Veradigm (MDRX) United States $0.507B 0.00
Butterfly Network (BFLY) United States $0.480B 0.00
Talkspace (TALK) United States $0.428B 128.00
TruBridge (TBRG) United States $0.347B 771.00
Outset Medical (OM) United States $0.320B 0.00
Health Catalyst (HCAT) United States $0.285B 0.00
Nyxoah SA (NYXH) Belgium $0.244B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.224B 0.00
CapsoVision (CV) United States $0.202B 0.00
Zepp Health (ZEPP) Netherlands $0.199B 0.00
KORU Medical Systems (KRMD) United States $0.157B 0.00
American Well (AMWL) United States $0.136B 0.00
Pulmonx (LUNG) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.123B 0.00
MDxHealth SA (MDXH) Belgium $0.120B 0.00
CareCloud (CCLD) United States $0.104B 3.95
ImmunoPrecise Antibodies (IPA) Canada $0.092B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.080B 0.00
111 (YI) China $0.061B 0.00
P3 Health Partners (PIII) United States $0.050B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00